Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq

MCRB stock price forecast

How will MCRB stock perform in 2026 and 2030?

This page primarily displays the projected price range for MCRB stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of MCRB, the development trends of Seres Therapeutics, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for MCRB. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Seres Therapeutics, Inc.'s financial performance and industry trends to provide short-term price predictions for MCRB stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year MCRB stock price forecast

Price target:
30.35 USD
+258.32%
Based on 1-year price forecasts from 31 analysts, the highest estimate is 44.08 USD, while the lowest estimate is 14.38 USD.

Analyst rating for MCRB

Based on ratings from 27 analysts over the past three months, the overall consensus is Buy.

Strong buy
5
Buy
15
Hold
4
Sell
0
Strong sell
3

Tez-tez beriladigan savollar

How has MCRB's EPS performed recently?

MCRB's EPS is projected to reach -- USD next quarter. Explore more Seres Therapeutics, Inc. financial data and stay up to date on the company's latest developments on the MCRB stock details page.

What is the revenue forecast for MCRB next quarter?

Seres Therapeutics, Inc.'s revenue is projected to reach 0.00 USD USD in the next quarter. You can view Seres Therapeutics, Inc.'s revenue and earnings on the MCRB stock details page.

What is the price target for MCRB?

Based on analyst estimates, the most likely target price for MCRB over the next 12 months is 30.35 USD, with a projected high of 44.08 USD and a projected low of 14.38 USD. To track whether this target is reached within the next year, you can view the MCRB stock price chart on the MCRB stock details page to check the current MCRB stock price, or follow the latest developments related to MCRB on the MCRB Stock News page.

What is the analyst rating for MCRB?

We collected ratings from 27 analysts who have evaluated MCRB stock over the past three months. Most analysts maintain a Buy outlook, and after aggregating all opinions, the overall consensus rating is Buy. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of MCRB stock in 2030?

Based on price forecasts and analyses of Seres Therapeutics, Inc. from Wall Street analysts and major investment banks, MCRB is projected to trade between 16.94 USD and 84.70 USD in 2030.

MCRB stock chart

MCRB stock details

MCRB aksiya narxining o'zgarishi

Oxirgi savdo kunida, MCRB aksiya 8.47 USD narxda yopildi, kun uchun narx o'zgarishi 3.04%.

Aksiya fyucherslari savdosi

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil
NASDAQ/
MCRB stock price forecast